Skip to content
10-K

Annual Report

SELLAS Life Sciences Group, Inc. SLS

0001390478-25-000003

← back to feed
Filed
Mar 20, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 19, 2025 90.85M sh
Shares Diluted FY 2024 · Dec 31, 2023 27.78M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$31.41M
Cash And Equivalents FY 2024 · Dec 31, 2023 $2.53M
Current Liabilities FY 2024 · Dec 31, 2023 $13.74M
Total Liabilities FY 2024 · Dec 31, 2023 $14.2M
Current Assets FY 2024 · Dec 31, 2023 $3.17M
Total Assets FY 2024 · Dec 31, 2023 $6.22M
Eps Diluted FY 2024 · Dec 31, 2023 −$1.34
Eps Basic FY 2024 · Dec 31, 2023 −$1.34
Sga Expense FY 2024 · Dec 31, 2023 $13.86M
Net Income FY 2024 · Dec 31, 2023 −$37.34M
Operating Income FY 2024 · Dec 31, 2023 −$37.87M
Stockholders Equity FY 2024 · Dec 31, 2022 $4.85M